[ad_1]
Olympus is involved in the production of Medi-Tate medical devices
The Japanese company Olympus Corporation agreed to invest $ 20 million in Medi-Tate, which developed a device for the treatment of enlarged prostate glands, said the Xenia Venture Capital shareholder on Sunday. In a separate communication, Olympus said that he also bought the rights to distribute the company's products and a purchase option that would allow her to take over 100% of the company. Founded in 2007, Medi-Tate focuses on the treatment of benign prostatic hyperplasia or prostate enlargement, a non-cancerous prostate growth that affects over 500 million elderly men around the world. His iTind device has already been approved for use in the European Union. "Olympus intends to use Medi-Tate technology to further expand the range of minimally invasive devices for surgical treatment in BPH and to strengthen urological activity," said Olympus. "The intention is to gradually implement the product by obtaining legal approvals and other appropriate licenses in selected countries." Xenia shares jumped by 22.9%, finishing at 1.23 shekels (33 cents). (Yoram Gabison)
The Israeli Fund is becoming a major player in global peer-to-peer loans
The Israeli Loan Guarantee Fund has become one of the world's largest peer-to-peer lenders after the Israeli insurer, Phoenix, has invested $ 40 million. This infusion has increased the assets of CCF, managed by the IBI company dealing in financial services, up to USD 340 million, four and a half years after its creation. Other sponsors include Menora, an Israeli insurance company that has invested $ 50 million in its own and its clients into the fund. CCF purchases online loans made by P2P lenders in the US, such as Lending Club, Prosper Marketplace and Upstart. Because P2P lenders operate online, they have lower overheads than traditional financial institutions, so lenders can get higher returns compared to savings and investment products offered by banks. The CCF claims that since 2014, it has recorded average returns of 5% to 8% per annum. There are a handful of P2P lenders in Israel, including eLoan, Blender and BTB, although CCF does not invest in them. (Eran Azran)
Aman creates a JV blockage with a Chinese company
Aman Group, a group of information technologies based in the suburbs of Tel Aviv in Bnai Brak, said last week that it is creating a joint venture with the Chinese Yunnan Investment Group to develop blockchain solutions for the Chinese market. "China has invested a lot of resources in the development of technological solutions for local and international use," said Aman CEO Ben Pasternak. "Thanks to the developed and proven Blockchain functions and know-how from Aman Group, the new JV will be able to easily implement this technology in projects in China, including in trade and finance, health care, logistics and agriculture." The partnership requires further cooperation between the two parties on additional financial technologies and large data projects, Aman said in the announcement during Tel Aviv China (Yunnan) – Israel Innovation Cooperation Forum. Aman provides digital, cybersecurity, data, software development, knowledge management blockchain and has about 2,000 employees. (The Marker Staff)
[ad_2]
Source link